A clinicopathological study on overexpression of cyclin D1 and of p53 in a series of 248 patients with operable breast cancer

British Journal of Cancer

Volumn 73, Issue 6, 1996, Pages 728-734

  Michalides, R ^a   Hageman, P ^a   Van Tinteren, H ^a   Houben, L ^a   Wientjens, E ^a   Klompmaker, R ^a   Peterse, J ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

Breast cancer; Cyclin D1; Immunohistochemistry; P53; Prognosis

Indexed keywords

CYCLINE; CYCLOPHOSPHAMIDE; ESTROGEN RECEPTOR; FLUOROURACIL; METHOTREXATE; POLYCLONAL ANTIBODY; PROTEIN P53;

ADULT; ARTICLE; BREAST CANCER; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CARBOXY TERMINAL SEQUENCE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PATHOLOGY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

EID: 0029883680     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.128     Document Type: Article

References (39)

1. BARTKOVA J, LUKAS J, MULLER H, LUTZHOFT D, STRAUSS M AND BARTEK J. (1994). Cyclin D1 protein expression and function in human breast cancer. Int. J. Cancer, 57, 353-361.
2. BISHOP JM. (1987). The moleculuar genetics of cancer. Science, 235, 305-311.
3. BODRUG SE, WARNER BJ, BATH ML, LINDEMAN GJ, HARRIS AW AND ADAMS JM. (1994). Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene. EMBO J., 13, 2124-32130.
4. BORG A, SIGURDSSON H, CLARK GM, FRENO M, FUQUA SAW, OLSSON H, KILLANDER D AND MCGURIE WL. (1991). Assocation of INTI HST1 exemplification in primary breast cancer with hormone-dependent phenolype and poor prognosis. Br. J. Cancer. 63, 136-142.
5. BUCKLEY MF, SWEENEY JE, HAMILTON JA, SINI RL, MANNING DL, NICHOLSON RL, DEFAZIO A, WATTS CKW, MUSHGROVE EA AND SUTHERLAND RL. (1993). Expression and amplification of cyclin genes in human breasl cancer. Oncogene, 8, 2127-2133.
6. CORNELIS RS, VAN VLIET M, VOS CBJ, CLETON-JANSEN A, VAN DE VIJVER MJ, PETERSE JL, MEERA KHAN P, BORRESEN A, CORNELISSE CJ AND DEVILEE P. (1994). Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumours without p53 mutations. Cancer Res., 54, 4200-4206.
7. DAVIDOFF AM, KERNS BM, IGLEHART JD AND MARKS J. (1991). Maintenance of p53 alterations throughout breast cancer progression. Cancer Res., 51, 2605-2610.
8. EBINA E, STEINBERG SM, MULSHINE JL AND LINNOILA RI. (1994). Relationship of p53 overexpression and up-regulation of proliferating cell nuclear antigen with the clinical course of non-small cell lung cancer. Cancer Res., 54, 2496-2503.
9. ELSTON CW AND ELLIS OL (1990). Pathology and breast cancer screening. Histopathology, 16, 109-118.
10. FAILLE, A. DE CREMOUX P, EXTRA JM, LINARES G, ESPIE M, BOURSTYN E, DE ROCQUANCOURT A, GIACCHETTI S. MARTY M AND CALVO F. (1994). p53 mutations and overexpression in locally advanced breast cancers. Br. J. Cancer, 69, 1145-1150.
11. FANTL V, RICHARDS MA, LAMMIE GA, JOHNSTONE G, ALLEN D, GREGORY W, PETERS G AND BARNES DM. (1990). Gene amplification on chromosome band 11c13 and oestrogen receptor status in breast cancer. Eur. J. Cancer, 26, 423-429.
12. FRYE RA, BENZ CC AND LIU E. (1989). Detection of amplified oncogenes by differential polymerase chain reaction. Oncogene, 4, 1153-1157.
13. GILLETT C, FANTL V, SMITH R, FISHER C, BARTEK J, DICKSON C, BARNES D AND PETERS G. (1994). Amplification and overexpression of cylcin D1 in breast cancer detected by immunohistochemical staining. Cancer Res., 54, 1812-1817.
14. GREENWELL A, FOLEY JF AND MARONPOT RR. (1991). An enhancement method for immunohistochemical staining of proliferating cell nuclear antigen in archival rodent tissues. Cancer Lett., 59, 251-256.
15. HARRIS CC AND HOLLSTEIN M. (1993). Clinical implications of the p53 tumour suppressor gene. N. Engl. J. Med., 239, 1318-1328.
16. HENRY JA, HENNESSY C, LEVETT DL, LEMMARD TWJ, WESTLEY BR AND MAY FEB. (1993). Int-2 amplification in breast cancer: association with decreased survival and relationship to amplification of c-erbB2 and c-myc. Int. J. Cancer, 53, 774-780.
17. HINDS PW, DOWDY SF, EASTON ENG, ARNOLDA AND WEINBERG R. (1994). A function of a human cyclin gene as an oncogene. Proc. Natl Acad. Sci. USA, 91, 709-713.
18. KAPLAN EL AND MEILER P. (1958). Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 53, 457-481.
19. KEYOMARSI K AND PARDEE AB. (1993). Redundant cyclin overexpression and gene amplification in breast cancer cells. Proc. Natl Acad. Sci. USA, 90, 1112-1116.
20. LAMMIE GA AND PETERS G. (1991). Chromosome 11q13 abnormalities in human cancer. Cancer Cells, 3, 413-420.
21. LEVINE AJ, PERRY ME, CHANG A, SILVER A, DITTMER DWU AND WELSH D. (1994). The role of the p53 tumour-suppressor gene in tumorigenesis. Br. J. Cancer. 69, 409-416.
22. LONN U, LONN S, NILSSON B AND STENKVIST B. (1994). Breast cancer: significance of c-erbB2 and int-2 amplification compared with DNA ploidy, S-phase fraction, and conventional clinicopathological features. Breast Cancer Res. Treat., 29, 237-254.
23. LUKAS J, PAGANO M, STASKOVA Z, DRAETTA G AND BARTEK J. (1994). Cyclin D1 protein oscillates and is essential for cell cycle progression in human tumour cell lines. Oncogene, 9, 707-718.
24. MANTEL N. (1966). Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother. Rep., 50, 163-170.
25. MARCHETTI A, BUTTITTA F, PELLEGRINI S, CAMPANI D, DIELLA K, CECCHETTI D, CALLAHAN R AND BISTOCCHI M. (1993). p53 mutations and histological type of invasive breast carcinoma. Cancer Res., 53, 4665-4669.
26. MICHALIDES RJAM, VAN VEELEN N, HART A, LOFTUS B, WIENTJENS E AND BALM A. (1995). Overexpression of cyclin D1 correlates with recurrence in a group of 47 surgically resected squamous cell carcinomas of the head and neck. Cancer Res., 55, 975-978.
27. MOTOKURA T AND ARNOLD A (1993). Cyclins and oncogenesis. Biochim. Biophys. Acta, 1155, 63-78.
28. MUSHGROVE EA, HAMILTON JA, LEE CSL, SWEENEY KJE, WATTS CKV AND SUTHERLAND RL. (1993). Growth factor steroid and steroid antagonist regulation of cyclin gene expression associated with changes in T47D human breast cancer cell cycle profession. Mol. Cell. Biol., 13, 3577-3587.
29. 1 phase in rodent fibroblasts. Genes Dev., 7, 1559-1571.
30. SCHUURING E, VERHOEVEN E, VAN TINTEREN H, PETERSE JL, NUNNINK B, THUNNISSEN FBJM, DEVILEE P, CORNELISSE CJ, VAN DE VIJVER MJ, MOOI WJ AND MICHALIDES RJAM. (1992a). Amplification of genes within the chromosome 11q13 region is indicative of poor prognosis in patients with operable breast cancer. Cancer Res., 52, 5229-5234.
31. SCHUURING E, VERHOEVEN H, MOOI WJ AND MICHALIDES RJAM. (1992b). Indentification and cloning of two overexpressed genes. U21B31-PRAD1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas. Oncogene, 7, 355-361.
32. SHERR CJ. (1993). Mammalian G1 cyclins. Cell, 73, 1059-1065.
33. SILVESTRINI R, BENINI H, DAIDONE MG, VENEROI S, BORACCHI P, CAPPELLETTI V, DI FRONZO G AND VERONESI U. (1993). p53 as an independent prognostic marker in lymph node-negative breast cancer patients. J. Natl Cancer Inst. 85, 965-970.
34. SUGARBAKER JP, GUNDERSON LL AND WITTES RL. (1985). Colorectal cancer. In Cancer: Prinicples and Practices of Oncology, De Vita VT, Hellmam S, Rosenberg SA. (eds) 2nd edn. pp. 800-803. Lippincott: Philadelphia.
35. THOR AD, MOORE DH, EDGERTON SM, KAWASAKI ES, REIHSAUS E, LYNCH HT, MARCUS JN, SCHWARTZ L, CHEN L, MAYALL BH AND SMITH HS. (1992). Accumulation of p53 tumour suppressor gene protein: an independent marker of prognosis in breast cancer. J. Natl Cancer Inst., 84, 845-855.
36. TSUDA H, HIROHASHI S, SHIMOSATO Y, HIROTA T, TSUGANE SD, YAMAMOTO H, MIYAJIMA N, TOYASHIMA K, YAMAMOTO T, YOKOTA T, YOSHIDA T, SAKAMOTO H, TERADA M AND SUGIMURA T. (1989). Correlation between long-term survival in breast cancer patients and amplification of two putative oncogene-coamplification units, hst-1 int-2 and c-erbB ear-1. Cancer Res., 49, 3104-3108.
37. VOGELSTEIN B, FEARON ER, HAMILTON S, KERN SE, PREISINGER AC, LEPPERT M, NAKAMURA Y, WHITE R, SMITS AMM AND BOS JL. (1988). Genetic alterations during colorectal-tumour development. J. Engl. J. Med., 319, 525-532.
38. WANG TC, CARDIFF RD, ZUKERBERG L., LEES E, ARNOLD A AND SCHMIDT EV. (1994). Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature, 369, 669-671.
39. WORLD HEALTH ORGANIZATION. (1981). Histological Typing of Breast Tumours, 2nd edn. World Health Organization: Geneva.